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Age related macular degeneration is a disease which occurs in aged individuals. There
are various changes that occur at the cellular, molecular and physiological level with
advancing age (Samiec et al., 1988; Sharma K. et al., 2014). Drusen deposition between
retinal pigment epithelium (RPE) and Bruch’s membrane (BM) is one of the key features
in AMD patients (Mullins et al., 2000; Hageman et al., 2001) similar to Aβ/tau aggregates
in Alzheimer’s disease (AD) patients. The primary goal of this review is to discuss whether
the various candidate genes and associated biomarkers, that are known to play an
independent role in progression of AMD, exert deleterious effect on phenotype, alone or
in combination, in Indian AMD patients from the same ethnic group and the significance
of such research. A statistical model for probable interaction between genes could be
derived from such analysis. Therefore, one can use multiple modalities to identify and
enrol AMD patients based on established clinical criteria and examine the risk factors
to determine if these genes are associated with risk factors, biomarkers or disease
by Mendelian randomization. Similarly, there are large numbers of single nucleotide
polymorphisms (SNPs) identified in human population. Even non-synonymous SNPs
(nsSNPs) are believed to induce deleterious effects on the functionality of various
proteins. The study of such snSNPs could provide a better genetic insight for diverse
phenotypes of AMD patients, predicting significant risk factors for the disease in Indian
population. Therefore, the prediction of biological effect of nsSNPs in the candidate
genes and the associated grant applications in the subject are highly solicited.Therefore,
genotyping and levels of protein expression of various genes would provide wider
canvas in genetic complexity of AMD pathology which should be evaluated by valid
statistical and bioinformatics’ tools. Longitudinal follow up of Indian AMD patients to
evaluate the temporal effect of SNPs and biomarkers on progression of disease would
provide a unique strategy in the field.
Keywords: age related macular degeneration, SNP, biomarkers, longitudinal analysis, snSNPs, bio-informatics
analysis, statistical modeling, Mendelian randomization
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INTRODUCTION
Diseases associated with aging are being reported with increasing
frequency due to enhanced human lifespan and/or risk
factors. Aging-associated diseases include arthritis, dementia,
Alzheimer’s disease (AD), AMD and cataract. The preclinical
studies on AMD and its treatment strategies are lacking due
to nonavailability of well characterized animal models as well
as absence of population based genetic epidemiological studies.
Mice lacking with monocyte chemoattractant protein-1 (CCL-2)
and its receptor CCR-2 was found to develop the cardinal feature
of AMD in mouse retina (Ambati et al., 2003). Recently, several
risk genes for AMD have been discovered by examining the
DNA samples from Caucasian (white with European ancestry)
subjects and have been found to be associated with CCL-
2 and complement factor H (CFH) polymorphisms. Other
genes are also being investigated in AMD pathogenesis in various
populations, some with conflicting and unverified reports, others
which are validated, however, equally large comprehensive
genetic studies from India, particularly from North-West India
remain limited thus impacting India’s reduced role in pioneering
AMDdiagnostics and therapies. It would be advisable to establish
a population based genetic profile database of Indian AMD
patients to dissect the role of specific genetic factors involved
in pathogenesis of AMD. This could be achieved by examining
AMD patients for major risk single nucleotide polymorphisms
(SNPs), biomarkers and risk factors including follow up of AMD
patients at the interval of 1 year for investigating SNP-phenotype
correlation as well as temporal association of biomarkers with
disease progression. The changes in SNPs of genes could be
analyzed for their impact on disease pathology by their changes in
structural and functional aspect by informatics approach. Thus, it
will provide an insight of how the changes at genomic level reflect
at the protein level, affecting protein function and contributing
towards the progression of AMD.
Briefly, the primary aim of this review is to discuss the role
of allelic variations among various genes and also to argue their
nature and causal effect on protein expression, AMD phenotype
and progression. Moreover, it is also to describe the need to
examine the role of socio-demographic and risk modifying
factors specific to Indian population in the pathogenesis of AMD
so that a well characterized AMD population database is created
for future drug targeting and clinical trials.
As a natural consequence of above cited literature in Table 1,
we emphasize the need to describe the interaction between
various gene’s SNPs and biomarkers across various loci in AMD
patients that could be causal to and prognostication of AMD
progression in Indian population. Moreover, identification of
the genetic susceptibility from population based studies could
be further encapsulated by proposing a statistical model which
can provide means to strategize public health initiatives through
new prevention and treatment schemes for those suspected of
suffering from AMD. Additionally, the conclusion of genetic
data could be strengthened by including a longitudinal follow
up of AMD patients in order to advance our understanding of
the effect of SNPs and biomarkers along the course of disease,
examine the clinico-pathological and etiological relevance of
these observations and to investigate whether these alterations
are a ‘‘cause’’ or a ‘‘consequence’’ of AMD. To further evaluate
how these SNPs lead to structural and functional abnormalities
in the protein, in silico studies would be required to confirm
the nature of SNPs by using standard bio-informatics tools.
The results of such bioinformatics analysis can provide a
biological annotation of nsSNP in the candidate genes. This
can predict the impact of variation in structure and function
of proteins. Disease risk can also be predicted based on effect
of nsSNPs on the function of protein in the early age of the
patients who will likely to have AMD in the later stage of their
life.
The integrative approach including statistics and
bioinformatics can deal with heterogenic complexity of AMD
genetics. In genome-wide association study (GWAS), missing
genetic links and implication of variants found in untranslated
region of the genome could be annotated by bioinformatics
analysis and could also predict the probable interaction between
various associated genes in disease pathology. Moreover, the
effect of environmental factors on genetic variants could be
correlated with Mendelian randomization approach or by
Sequential Kernel Association Test (SKAT) analysis. Hence,
the integrative approach in AMD genetics could enhance
the productivity and better translational benefit in such
studies.
KEY QUESTIONS NEED TO BE
ADDRESSED IN INDIAN AMD GENETIC
STUDIES
AMD is a degenerative disease of eye with irreversible
central vision loss in old age. There is no reliable treatment
and diagnostic or prognostic biomarkers unique to Indian
population. Therefore, wemust have to drive such genetic studies
which may result not only in the discovery of new biomarkers for
validation of new therapies and monitoring treatment outcomes
but also investigating the role of SNPs in disease prognosis.
Such studies will also resolve the conflicting reports on the
association of various loci, candidate genes and associated SNPs
by examining them in the same population.
Also, the following key questions need to be addressed in
Indian AMD scenario:
• Is there any one or set of novel SNPs or biomarkers causal to
Indian AMD?
• What is the expression profile of such biomarkers analyzed
at the certain time intervals by recruiting Grade 3 (AREDS)
AMD patients and if these are causally related to the disease
progression?
• Is there any gene-demography or SNP-protein association
which can be linked to AMD by either a predictive model
for probable interaction between genes or by Mendelian
randomization or bioinformatics approach?
• Do the SNPs or nsSNPs result in changes in secondary and
tertiary structures of proteins coded thus impacting their
function?
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TABLE 1 | The overview of Indian AMD investigations carried out in India showing various risk loci that have neither been examined collectively in one
set of patients nor analyzed for SNPs.
Study Age Region Diagnostic Subjects/ Sample Alleles Other Reference
design range criteria Type of size or genes
used controls SNPs
1 Case 68.8 ± 3.1 years South AREDS AMD/Normal 250 rs713685 FBLN6 Kaur et al. (2010)
control of for wet AMD, India control rs6518799 FBLN5
TIMP3 64.4 ± 4.8 years rs743751 MMP2
for dry AMD MMP1
MMP3
DCN
LUM
EPYC
TIMP2
MMP9
2 Case 68.8 ± 3.1 years South AREDS AMD/Normal 250 rs1061170 LOC387715 Kaur et al. (2008)
control of for wet AMD, India control HTRA1
CFH 64.4 ± 4.8 years
for dry AMD
3 Case 62.4 ± 10.2 South AREDS AMD/Normal 100 rs1061170 TLR4, APOE Kaur et al. (2006)
control for early AMD, India control rs3766404
of CFH 69.2 ± 7.7 rs3753394
for late AMD rs800292
rs3753396
rs1065489
4 Case – South – Diabetic 120 Promoter Nitric Suganthalakshmi et al. (2006)
control India Retinopathy/ region oxide
study VEGF diabetic control
5 Case control 66.56 North Age and AMD/ 133 rs4586 (CCL2), – Anand et al. (2012)
study for India diagnosis normal rs1799865 (CCR2)
Ccl2 and Ccr2 for AMD control
6 Case control 60 South Wisconsin AMD/ 3569 rs1061170 for CFH HTRA1, Sundaresan et al. (2012)
study for India Age-Related disease rs10490924, C2,
ARSM2 and Maculopathy control rs2672598, CFB
CFH Grading System rs10490923 for ARSM2
7 Case control 66.56 North Age and AMD/ 115 rs1531289 and Sharma et al. (2012)
study for India diagnosis normal rs2305948
VEGFR2 for AMD control for VEGFR2
8 Case control 66.56 North Age and AMD/ 115 rs1061170 Sharma et al. (2013)
study India diagnosis normal for CFH
for CFH for AMD control
9 Case control 66.5 North Age and AMD and 115 rs3775291 Sharma N. K. et al. (2014)
study for India diagnosis normal for
TLR-3 for AMD subjects TLR3
• Do the risk factors like diet, smoking, alcohol consumption,
co-morbidity etc influence the molecular progression or
severity of the disease?
COMPLEX GENETIC NETWORK IN AMD
PATHOLOGY
AMD is a third most devastating eye disorder which is
characterized by irreversible and incurable hampered
vision due to degeneration of macula affecting more than
50 million elderly people in the world. Macula consists
of high density of photoreceptors which helps in central
and sharp vision. AMD is prevalent in about 2% of people
over the age of 50 which rises about 8% in >65 years
old and 20% of those over 85 years of age having this
condition.
AMD can be categorized into dry and wet forms. Drusen
deposition in between the retinal pigment epithelium (RPE) and
choroids is a characteristics feature of dry AMD. The abnormal
neovascularization of choroids penetrate the RPE and disrupt its
integrity. These abnormal choroidal blood vessels are leaky in the
nature therefore leads to development of wet AMD.
AMD literature is replete with both confirmatory and
conflicting reports of over 19 major genes and their SNPs which
have been postulated to be associated with AMD but with
very limited large studies examining all the alleles in the same
study thus hampering its translation into clinical application.
We provide here one example of our experience with another
neurodegenerative disorder in order to highlight the value of
gene demography investigations in Indian scenario. Our study
on Parkinson’s Disease (PD) patients in North-West region
of India revealed 40% PARK2 mutation screened by single
strand conformation polymorphism (SSCP) in these patients
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which had never been exposed with smoking. We compared
the demographic and community data of other neurological
patients with PD patients, found Sikh and female patients
from rural background exhibit significantly higher PARK2
mutation as compared to urban and male population. We also
examined the age of onset of PD in rural background which
was significantly lower as compared to urban background PD
patients (Prabhakar et al., 2010; Vinish et al., 2010). Therefore,
the inclusion of alleles or SNPs-demographic association studies
a large set of population could assist to examine the demographic
parameters with disease progression that are relevant to Indian
scenario.
The environmental factors share the causal effect along with
genetic factors in AMD pathophysiology. Environmental factors
include smoking, high cholesterol diet, carotinoid, Vitamin A,
Vitamin E, zinc, age, sex etc.
Several environmental factors have been reported for AMD
progression which includes cigarette smoking, (Seddon et al.,
1996) higher body mass index (BMI; Seddon et al., 2003),
and dietary carotenoids (van Leeuwen et al., 2005). Human
hepatic lipase is one of the important lipase and plays an
important role in lipid metabolism which convert intermediate-
density lipoprotein to low-density lipoprotein. It is abundantly
expressed in hepatic cells and adrenal gland. Polymorphism
of LIPC has shown strong evidence for their relation with
pathogenesis of AMD. Seddon et al. (2010) have conducted
GWAS and found protective effect of TT genotype vs. CC
genotype. It further revealed that SNP variation at promoter
region (rs1046817) which influence the LIPC expression, have
showed strong association with AMD pathogenesis independent
to demographic and environmental factors. Recently, Neale et al.
(2010) revealed the LIPC variance rs493258 and its correlation
with AMD pathology, and also demonstrated that LIPC
variances rs493258 along with rs10468017 strong association
with advanced AMD progression by influencing the HDL levels.
Tissue inhibitor of metalloproeinase-3 (TIMP-3) is another
known regulator of the functioning of metalloproteinases and
can degrade the extracellular matrix (ECM). TIMP-3 plays an
imperative in maintaining the ECM and has been found to be
anti-angiogenic. In a genome wide association study conducted
by Chen and colleagues, they identified a susceptibility locus
in AMD pathology near TIMP3. Additionally, they have also
revealed the strong association with LIPC polymorphism in
the same set population in AMD patients (Chen et al., 2010).
In an Indian study Kaur et al. (2010) has found that a SNP
identified at ≈100 kb upstream of TIMP-3 was associated with
AMD.
TIMP3 is an ECM protease and has been found to be anti
angiogenic (Sang, 1998). In a GWAS, Chen et al. (2010) along
with another separate study it has been found that a SNP present
at ≈100 kb upstream of TIMP-3 raises the vulnerability to AMD
in diverse populations. It has been suggested that elevated level
of TIMP-3 in eyes in AMD results in thickening of Bruch’s
membrane (BM; Kamei and Hollyfield, 1999), and recent study
on human RPE has shown that TIMP-3 is one of the strongest
candidate gene in AMD pathophysiology (Strunnikova et al.,
2010).
Immediate Early Response-3 (IER-3) is another regulatory
protein involved in apoptosis mediated by NF-κB pathways.
The expression levels of IER-3 could be enhanced by various
cellular responses, viral infection, and with interaction with
cytokines. The IER-3 was also found to be involved in systemic
immunity and in cardiovascular system. The knockout study
revealed that IER-3 deficiency could hamper the immunity,
inflammation and genomic stability (Arlt and Schäfer, 2011).
This group has also found the effect of IER3 which interacts
with various signaling network specifically NF-kB, MAPK/ERK
and PI3K/Akt and have been found to have abnormal
immune function and increased inflammation with hypertension
and impaired in genomic stability (Sasada et al., 2008).
Moreover IER-3 has also been found to be upregulated in
apoptotic processes in Sezary (SzS) which was mediated by
TNF-α in patient lymphocytes which might be linked to
its pathogenesis. Akilov et al. (2012) investigated that CD4+
(CD26) lymphocytes of SzS found IER-3 upregulation, with
low level of intracellular reactive oxygen species (ROS) and
reduced TNFR1 expression in patients. Steensma et al. (2009)
described have shown the IER-3 genes was translocated in
the patients of myelodysplastic syndrome (MDS), markedly
decreasing expression.
On the other hand, Vazquez-Chona et al. (2005) have
shown the genetic network in injured retina and found
increased expression of IER-3 gene with other transcription
factors such as Crem, Egr1, Fos, Fosl1, Junb, Egr1, Btg2,
Atf3, and Nr4a1 etc. In addition to this, Gupta et al. (2005)
have demonstrated the protein levels in human lens epithelial
cells induced with glucocorticoid and found down regulation
of IER-3 gene in microarray analysis which was further
confirmed by real time PCR. These genes are involved in
angiogenesis and can exert their additive effect on AMD
pathogenesis which may be independent to CFH mediated
pathology.
Solute carrier family 16 member 8 (SLC16A8: 53kDA or
Monocarboxylate transporter 3) is a transporter family works
by proton motive force mediated by transportation of many
monocarboxylates such as lactate. Pyruvate and branched-
chain oxo-acids derived from Leu, Val, Ile, ketone bodies
transport across cell membranes. Apart from transport function
across plasma membrane, its role was also found in leucocytes
migration and blood coagulation. Human RPE and choroids are
the two retinal tissues where the expression of MCT-3 was
found abundantly. Among both, RPE expresses more amounts
ofMCT-3 then choroid plexus epithelium in the basal of the cells
(Philp et al., 2001).
Daniele et al. (2008) have reported the altered vision in
SLC16A8 knockout mice. MCT3−/− mice have been shown to
have lost expression of CD147, which form heteromer complex
with MCT-3, from basolateral membrane of RPE but not from
apical RPE resulting in reduced α-waves amplitude of scotopic
electroretinogram and four folds increase in lactate in the retina
consequently decreasing the pH of outer retina. In addition
to this, Gallagher-Colombo et al. (2010) have demonstrated
the decreased expression of MCT-3 while healing of wound
generated by scratch in chick RPE cells and human fetal (hf)
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RPE culture that may induce to pathologic phenomenon in the
retina. The migrating cells at the site of wound demonstrated
enhanced expression of MCT4 and lacking the expression
of MCT-3.
Recent study by Takeda et al. (2009) had shown CCL-11
and CCL-24 expression elevated in the mice treated with
laser and further neutralization of both CCL-11 and CCL-24
with antibody significantly reducing the area of choroidal
neovascularization (CNV) in the mouse retina, indicating its
causal role in pathogenesis of AMD. Moreover, it has also been
demonstrated that ciliary neutrophic factor (CNF) formation
mediated by Eotaxin-CCR-3 signaling, suggests the active role
of Eotaxin-CCR3 in choroidal endothelial cell proliferation in
CNV formation which have been reduced by the administration
of neutralizing antibody of Eotaxin-CCR3. Furthermore, the
knockout mice of eotaxin and its receptor CCR3 have been
shown to have protective effect on laser induced CNV (Wang
et al., 2011). Lately, it has been demonstrated that the angiogenic
(Humbles et al., 2004) as well as allergic reactions in the
body could be regulated by eotaxin with the involvement of
mast and eosinophils (Salcedo et al., 2001). It was found that
eotaxin-CCR3 inhibition could regulate CNV formation strongly
as compared to vascular endothelial growth factor (VEGF)
regulation.
DICER-1, a multi-domain protein, is another important
enzyme for synthesis of short interfering RNAs (siRNAs
∼21–25 nucleotides) from pre-double-stranded RNAs during
RNA interference. DICER-1 is the miRNA processing enzyme
that is required for the maturation of miRNAs. If there is
any defect in the DICER-1 then most of these RNAs cannot
be generated. About 30% of the human genes are regulated
by micro RNA classes of small RNA. However, mammalian
DICER-1 appears to play an important function in visual
activities by degrading toxic RNA. It was recently reported
that accumulation of transcripts of Alu RNA in the geographic
AMD was caused due to dysregulation in the DICER-1. Kaneko
et al. (2011) showed that the mice deficient in DICER1
in RPE caused damage to the RPE similar to geographic
atrophy. Mammalian DICER-1 has also been recently reported
to be involved in visual activities by degrading toxic RNA.
It was reported that accumulation of transcripts of Alu RNA
in the geographic AMD was caused due to dysregulation in
the DICER1 (Figure 1). Kaneko et al. (2011) showed that
the levels of DICER1 were found to be reduced in the advanced
form of AMD i.e., geographic atrophy in AMD patient’s
RPE.
In SOD1−/− mice model, the role of SOD1 which plays
protective mechanism against nascent oxygen has already been
reported. This impaired mechanism leads to the degenerative
changes in the retina of SOD1−/− mice. They have also shown
cardinal features of AMD pathology in SOD1−/− mouse retina
like thickening of BM, CNV and drusen etc (Valentine et al.,
2005). The adeno-associated virus (AAV) ribozyme mediated
degradation of SOD2 mRNA in RPE of the wild-type mice
cause SOD2 deficient mice (Justilien et al., 2007). This SOD2
deficient mouse had BM and RPE changes and elevated
level of A2E and lipofuscin accumulated in RPE (Kasahara
et al., 2005). It has also been reported that the oxidative
stress elevates the chance of the ocular neovascularization
and can induce inflammation which lead to AMD. Several
studies have demonstrated that significant association between
genetic variation in CFH gene and AMD pathophysiology.
In last few years, it has been found that genetic factors are
strongly associated with incidence of AMD. Among these
genetic factors, CFH, which is located on chromosome 1q32
and HtrA serine peptidase 1 (HTRA1), which is located
on chromosome 10q26, are found more strongly associated
with AMD. However, the molecular mechanisms need to be
clarified. However, various studies have shown the interaction
of CFH with ARMS2 and HTRA (Huang et al., 2015) including
smoking. Moreover, oxidized lipids also can show the higher
affinity with CFH molecules which further can stimulate
the macrophages to release the angiogenic (like VEGF) or
proangiogenic molecules (like IER-3, IL-6/8; Sharma K. et al.,
2014).
Genetic variants, especially complement system’s
components, shows well-built association with AMD, defines
the involvement of innate immune system. Therefore, the
innate immune components, complement system and Toll-
like receptor (TLR) which acts as pattern recognition (PRR)
molecules for innate immune system (Kumar et al., 2004; Liu
et al., 2008) function in response to their respective ligand in
two ways: by stirring up the phagocytosis of target molecules
and by activating the signal pathways that can provoke the
expression of cytokines and other inflammatory mediators
(Park et al., 2007; Van Beijnum et al., 2008). These augmented
and sustainable inflammatory responses in RPE cells, by
complement system, by TLR signaling, or by the co-activation
of both, can stimulate the drusen formation in macula.
Schröder and Bowie (2005) accounted for strong association
between TLR4 (a bacterial endotoxin receptor) variants and
increased risk of AMD susceptibility. Yang et al. (2008) showed
that TLR3 variance rs3775291 plays a protective role in GA
patients.
Various investigations have shown that the CFH gene
on chromosome 1q31 is the first major AMD susceptibility
gene (Zareparsi et al., 2005). The association of increased
risk of AMD is reported to result from the Y402H variant
in exon 9 (rs1061170, T > C, Sepp et al., 2006). CFH
gene regulates the both alternative and classical complement
pathways, therefore maintain the complement system mediated
immunity. Any genetic variation in CFH gene which leads
to structural or functional changes are believed to lead AMD
pathology.
VEGF has been reported to be strongest angiogenic factor
responsible for CNV in case of wet AMD pathology. A study
of Taiwan, Chinese and English population has shown positive
correlation between genetic variation of VEGF-A gene and
AMD pathology (Churchill et al., 2006; Lin et al., 2008).
On the contrary, Boekhoorn et al. (2008) did not reveal
significant association in AMD pathology and polymorphisms
of VEGF gene. Similarly, VEGF also plays an important role in
AMD and corneal pathogenesis by inducing neovascularization
(Philipp et al., 2000; Carneiro et al., 2011). VEGF binds to
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its three receptors viz., VEGFR-1, VEGFR-2, and VEGFR-3,
and co-receptors such as neurophilin and heparan sulfate
proteoglycans (Hiratsuka et al., 1998).
Transforming growth factor-β (TGF-β) cascade is another
important signaling network that acts upon TGFBR-1 and
type II TGF-β receptors forming a heteromeric complex and
transducing signal from the cell surface to the cytoplasm. TGF-β
shows serine/threonine kinase activity and predominately
expressed in highly active organs like heart and brain. Several
important cellular functions are regulated and govern by TGF-β
including apoptosis, conversion of epithelial to mesenchymal,
hypoxic condition, artrial morphogenesis, transcriptional
regulation, colagen fibril organization and signal transduction.
Recently, meta-analysis by Fritsche et al. (2013) on GWAS has
demonstrated 19 genetic loci which have shown the significant
correlation with AMD pathology. In this study, Collagen type
XV and TGFBR-1 have found that both genes are located on
chromosome 9q22.33. It has been reported that type XV collagen
was found to have much expression in cells present at base and
provide strength to vessels. The heterozygous mutation in either
TGFBR-1 or TGFBR-2 was found to have new phenotypes which
include perturbations in cardiovascular, skeletal development
and neurocognitive systems. The expression levels of these
proteins, higher in both collagen and connective tissue growth
factors, with elevated level of phosphorylated SMAD2 indicated
increased TGF signaling despite not responding to TGF signaling
in mutated alleles (Loeys et al., 2005). VEGF, basic fibroblastic
growth factor-2 (FGF2), TGFβ-1, 2, 3, and TGFBR-1, 2, 3
are known as angiogenic factors. Enhanced mRNA levels
were reported in tissue sample of cancer and neoplasia, and
found elevated parallel to increased severity of disease as
compared to that of normal cervical tissues (Soufla et al.,
2005).
RAD51 family members are involved in DNA repair
generated during recombination and by DNA damaging agent
by homologous recombination. RAD51B can regulate the several
cellular activities by delaying the G1 cell cycle and inducing
the apoptosis. These processes mediated by RAD51B could be
induced by damage in DNA fragment (Figure 2). Three isoforms
by alternative splicing of RAD51B have been identified yet.
Various SNPs studies on RAD51B gene demonstrated important
genetic factor contribute to breast cancer and colon cancer
pathogenesis. Hamdy et al. (2011) revealed genetic variation in
RAD51B, RAD51 (G135C) andXRCC3 (Thr241Met) genes found
to be significantly correlated with leukemia pathology in cancer
patients.
A disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS) family proteins include various domains
like thrombospondin type-1, metalloproteinase etc. These family
proteins involve in proteolysis and several other biological
processes like development and angiogenic processes. Bevitt et al.
(2003) investigated the ADAMTS expression in RPE cells which
are transcriptionally regulated by TNF-α signaling pathway.
Mckie et al. (2003) have revealed the ADAMTS expression levels
in response to TNF-α stimulation in ARPE-19 cells. Increased
expression of ADAMTS1, ADAMTS6 and ADAMTS9 by TNF-α
suggested their possible role in inflammatory conditions of
retina. Moreover, expression of other ADAMTS in response
to TNF-α also showed that ADAMTS families have their
role in neovascularization, processing of collagen and cleavage
of proteoglycan (Mckie et al., 2003). Expression regulation
of ADAMTS family by TNF-α in retinal layers suggest the
crucial role of these proteins in AMD and other inflammatory
diseases.
Beta 1,3 glucosyltransferase (B3GALTL) encodes enzyme beta
1,3-galactosyltransferase-like which is located on chromosome
number 13q12.3. This enzyme is involved in glycosylation of
proteins. The B3GALTL gene is normally turned on in most
cells of the body, which suggests that the B3Glc-T enzyme
plays an important role in cellular function. Mutation in
this gene cause eye disease known as Peter’s plus syndrome
in front part of the eye called anterior chamber. Peter’s
anomaly, characterized by attachment of cornea with iris and
clouding of cornea, leads to blurred vision. This prominent
mutation was discovered at c.597-2A > G position (located
in CpG island). Bioinformatics analysis has revealed that this
mutation causes the pre mRNA structural changes at secondary
level. This mutation also suggests the role of epigenetic in
modulation of secondary structure at mRNA level consequently
can alter the expression of this protein and can also show
the pleiotropic effect on several eye disorders (Siala et al.,
2012).
Age-related maculopathy susceptibility 2 (ARMS2) gene
is one of the genes which has widely been studied and
replicated in several ethnic groups worldwide (Fuse et al.,
2011). ARMS2 location predominantly occurs at high energy
demanding tissue like mitochondria-concentrated part of human
photoreceptor cells. SNP variation in ARMS2 genes could lead
to reduced stability of the ARMS2 mRNA (Fritsche et al.,
2008).
HTRA1 is serine proteases which is composed of four
protein domains for binding of Insulin-like growth factor
binding domain (ILGF), a kazal domain, a trypsin-like
peptidase domain and a PDZ domain to accomplish different
cellular functions. Recently, it has also been discovered by
INDEYE study that polymorphisms in ARMS2/HTRA1 locus
are significantly associated with early and late AMD but
instead of this locus the complement factors components like
C2, CFH and complement factor B (CFB) have not shown
positive correlation with AMD pathology (Sundaresan et al.,
2012).
Activation or dysregulation of several complement factors
of alternative complements pathway like CFH, C2, complement
factor I (CFI) and CFB have been found to be associated with
AMD pathogenesis by releasing local inflammatory activating
products. Several complement factor especially alternative
complement pathway genes have been reported in pathogenesis
of AMD (Figures 1, 3). Thakkinstian et al. (2012) pooled data
from 19 studies which happened between 2006 and 2011 for
4 SNPs: rs9332739 and rs547154 for C2 gene and rs4151667
and rs641153 for CFB gene and suggested the robust estimate
that these alleles contributed to lowering the risk in all AMD
pathogenesis in Caucasian population by 2.0% to 6.0%. Recently,
it has been examined that complement factor B polymorphism
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FIGURE 1 | Schematic representation of various genes loci and their linkage to AMD. Illustration showing the toxicity of Alu miRNA and/or degraded
retroviral RNA can activate of NF-κB pathway mediated through Toll-like receptor 3 (TLR3) receptor. Stimulation of angiogenic (e.g., vascular endothelial growth
factor, VEGF, Transforming growth factor-β receptor 1,TGFβR1), inflammatory and apoptotic pathways in retinal pigment epithelium (RPE) cells by oxidized lipid
metabolites (e.g., 7-ketocholesterol) and apolipoproteins may signify the role of proteins (e.g., Lipase C, LIPC) involved in such processes. Additionally, increase of
pH or concentration of monocarboxylic acid inside RPE cells which is regulated by transporter proteins (SLC16A8), can also hamper RPE cells function.
(R32Q) greatly correlated with early AMD but have protective
effect on late AMD in Caucasian population (Mantel et al.,
2013).
Meta analysis based on GWAS by Holliday et al. (2013)
have reported that CFH and ARMS2 SNPs are significantly
correlated with early AMD pathogenesis, and also suggested the
polymorphisms of Apolipoprotein E (APOE) associated with
early AMD out of many genes which have been studied in this
study. This study also suggested that genetic variants were less
effective in causing the pathogenesis of early AMD as compared
to late AMD (Holliday et al., 2013).
Another gene cholesterylester transfer protein (CETP) is
involved in reverse transfer of insoluble cholesteryl esters in
the reverse transport of cholesterol and found to be associated
with AMD pathogenesis. In 2010, a GWAS was conducted
which reported an association of HDL with susceptibility
towards AMD. The group conducted the study among 2157
cases and revealed strongest association signals of two genes
namely LIPC and CETP with AMD (Chen et al., 2010).
However, in recent case control study conducted in Chinese
population having AMD (n = 535) CETP was studied as
one of the gene among 10 genes having different variants.
No significant association of CETP was shown in AMD
patients. This might be possible that in case of genetic
studies different genes might respond differently (Tian et al.,
2012).
Tumor necrosis factor receptor superfamily 10A
(TNFRSF10A) signaling plays a crucial role in apoptosis
in cells. It has been identified as an important risk factor
significantly correlated with AMD pathology. A GWAS carried
out in 2011 among 1536 patients of AMD in Japanese population
showed a significant association of disease susceptibility with
TNFRSF10A gene on chromosome 8p21 (Arakawa et al.,
2011).
Collagen is an important protein component of ECM and
plays crucial role in cell-cell and cell-ECM adhesion. COL10A1 is
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FIGURE 2 | Proposed mechanism and outstanding questions in AMD pathogenesis. The various cellular functions like apoptosis, tumorigenesis, homologous
recombination, angiogenesis, and inflammation are being regulated by different genes which propose to stimulate the cardinal feature of AMD pathology.
a gene for collagen protein and its normal function is important
for neo vascularization. However, it is shown to be involved
in risk factor for AMD disease. In 2011 study of genotypes of
2594 cases collectively studied the VEGF and COL10A1. This
study with 2594 cases and 4134 controls recruitments. Total
6036699 SNPs from 1000 Genomes Project reference genotypes
were analyzed and found two new common susceptibility
alleles, near FRK/COL10A1 and VEGF-A for AMD (Yu et al.,
2011).
In all the above studies none have comprehensively examined
the above loci or associated SNPs, their protein correlates and
their role in AMD phenotype in a longitudinal fashion either in
the Caucasian or Indian population.
Genotyping and evaluating associated variants may be more
appropriate which can be analyzed by deriving a statistical
model to find probable interactions and communication between
complex set of genes. Hageman et al. (2011) have put
forward a statistical model based on gene-gene interaction
in AMD association studies and without accounting the
environment factors like smoking, BMI, etc which might
introduce inaccuracies in calculation. Moreover, Seddon et al.
(2009) have analyzed unconditional logistic regression for
genetic, ocular as well as environmental variables and the scores
to discriminate progressor was found to be significant. Lately,
Grassmann et al. (2012) have developed a statistical model to
reveal the probable interaction between genetic variants and
different environment factors. They have developed genetic risk
score (GRS) for AMD for 13 genetic variants and exhibited
good discriminative accuracy. In addition to AMD, the statistical
modeling in other diseases have been established and validated.
We have previously validated the Hosmer–Lemeshow goodness
of fit statistic and provide binary logistic regression model in
Amyotrophic Lateral Sclorosis (ALS) pathology (Gupta et al.,
2012). Therefore, for better assessment of genes interaction
and regulation with or without including environmental factors
can be analyzed by statistical modeling which can open
a new vista in diagnostic field and management of AMD
pathology.
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FIGURE 3 | Schematic representation of different genes and their association with AMD pathogenesis. Drusen accumulation between RPE layers and
Bruch’s membrane (BM) may be regulated through the components of alternative complement pathway (e.g., CFH, complement factor I (CFI), C2 and C3)
consequently leads to the formation of membrane attacking complex (MAC) and/or can also guide the choroidal neovascularization (CNV) by interacting with
extracellularmatrix (ECM) proteins (e.g., Fibulin 6, collagen) or ECM maintenance proteins (TIMP-3, ARMS2 or HTRA-ARMS2, collagenase etc). Moreover, impaired
function of cholesteryl estertransfer protein (CETP) and APOE may stimulate the deposition of apolipoproteins or other lipid metabolites assisting the formation of
drusen along with complement factors or leading to degeneration of RPE by interacting apoptotic proteins or protein regulates apoptotic pathway (e.g. tumor
necrosis factor receptor superfamily 10A (TNFRSF10A) etc).
Hence, in addition to statistical modeling, using
computational approach, we can analyze the effect of nsSNPs
observed in the candidate genes in the AMD patients. We
can map nsSNPs onto the biologically significant features of
proteins such as domains, families, folds, post-translational
modifications (PTMs) and protein sorting motifs. These
features are known to play important role in predicting
the protein function. Thus, it can provide an insight how
the changes at genomic level reflects at the protein level,
affecting protein function and leading to the progression
of AMD. The study of nsSNPs in candidate genes provides
better understanding of the phenotype variation in North
Indian AMD patients. Therefore, the statistical modeling
and bioinformatics analysis would greatly strengthen the
outcome of AMD research as it would enable prediction of
probable interaction between different genes variants and
risk factors and structural, functional changes in proteins
respectively.
AMD is a heterogenic and multi-factorial disease which can
also be influenced by environmental factors. We can address the
missing genetic links and examine the probable interaction
between gene-gene and gene-protein by bioinformatics
analysis and can map the mechanistic network. Such
genetic studies can provide probable diagnostic/prognostic
markers and new therapeutic targets for the disease by
selecting common or novel molecules from such genetic
network.
The predictive interactions and statistical modeling of various
variants analyzed byGWAS could provide the biggermechanistic
canvas at the genomic level. Therefore, we can identify new
target therapy in such complex heterogenic disease (for both
avastin responder and non-responders) and/or can also assist
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the prevailing therapies (like anti-VEGF therapies) based on
individual genetic interactions.
STATISTICAL ANALYSIS AND MODELING
Mendelian randomization analysis on epidemiological
studies has been shown to remove many potential biases
and confounding factors. It helps in increasing the robustness of
data (Thomas and Conti, 2004). Mendelian randomization
is a technique based on second principle of Mendelian
genetics i.e., the law of random assortment which suggests
two traits can be inherited in the progeny independent to
each other (Bochud and Rousson, 2010). In conventional
studies the association of genetic and phenotype variation
is used to describe the gene function, and the mode of
assessing the genetic variation is done by analyzing the
SNPs that are sufficient and frequent in a population for
making significant comparisons. Mendelian randomization
uses genetic epidemiology to make causal inference of a
disease (Smith and Ebrahim, 2003; Lawlor et al., 2008).
Mendelian randomization is an application of Instrument
variables (IV) and thus uses genetic information as its IVs
(Valentine et al., 2005). Formally, an IV is a variable/genotype
(Z) that follows a set of conditions. The outcome of
Z is correlated with the exposure to be analyzed and
its independent value not associated with confounding
factors (U) effects. Therefore, Z is independent results
of X and Y which shows the association between Y,
X and its confounding factors (U) (Thomas and Conti,
2004).
However, linkage disequilibrium (LD) approach has been
widely used in the several studies that show the association
among genetic alleles in a set of population to discover
the genetic markers. LD and pleiotrophic are the two
conditions which can be used to identify and understand the
function of specific gene variant in homogeneous population.
These genetic variants could show the pleiotrophic effect on
expression of that or other associated genes via involvement
of various biological pathways in presence of modifiable
exposure (environmental factors). These could be used to
analyze the biological interaction between genetic variants and
modifiable factors (Thomas and Conti, 2004). Therefore, LD
can show the interaction between the selected genotype and the
polymorphism then the association of modifiable exposure risk
factors to outcomes may be confounded (Thomas and Conti,
2004).
Typically, an equation representing the variables can be
derived as:
For p variant size observed lets assume ‘‘n’’ subjects from
a region are sequenced. Age, gender, and SNP variants could
be included as covariates for population stratification. Hence,
phenotype variable for i-th subject can be represented as:
Xi = (Xi1,Xi2, . . . ,Xim)
and genotype model can be represented as
Gi = (Gi1,Gi2, . . . ,Gip)
Lets assume 0, 1, or 2 the copy number of minor alleles present
in genetic analysis of set of genes which could show the additive
effect on disease phenotype. Logistic model could be represented
as:
logit
[
P(yi = 1)
] = α0 + α′Xi + β′Gi
For SKAT analysis on same set of genes in a population
and their correlation with environmental factors could be
compute by assuming the null hypothesis as H0: β = 0, that is,
β1 = β2 = . . . = βp = 0, so model can be represented as :
Q = (y− µˆ)′ K (y− µˆ)
Here K is Karnal function.
To correlate genotypes and phenotypes, including effects of
covariates like age, sex etc, one may carry out SKAT. This
procedure is available in R software as well as in SAS (Statistical
Analysis Software). Marginal effects in gene interaction and
correlation can also be obtained by using General Linear
Model (GLM), available in SPSS (Statistical Product and Service
Solutions).
The effect of confounders on genetic variants and its role
could be explained by statistical modeling like Mendelian
randomization, logistic modeling (which takes care of categorical
variables like smoker/non-smoker etc.) and SKAT analysis.
Epistasis phenomenon has been shown in various studies
to detect the effect of different genes interaction with CFH
and AMD phenotypes (Maller et al., 2006). Apart from
epistasis phenomenon, additive effect could also be seen
amongst various genes and their role in advancement of AMD
pathology.
BIOINFORMATIC ANALYSIS OF SNPs IN
GENES
To analyze the effect of snSNP of genes we can employ
following workflow as shown in Figure 4. The information
of various domain, families and motifs like protein sorting
motifs, coiled-coil motifs and regulatory motifs could be
matched with existing database. Important amino acid
residues in protein sequences which include PTMs (post
translational motifs), active sites, cleavage sites and binding
sites can also be included in the dataset. These features
are known to play important role in determining the
protein function. These protein features can be taken
from: (i) Human Protein Reference Database (HPRD)
[PMID: 18988627], which contains manually curated
information pertaining to the biology of human proteins;
and (ii) Swiss-Prot database, which comprises of highly
curated information about proteins. In-house Python scripts
can be used to map the nsSNPs onto significant protein
features.
To interpret the impact of nsSNPs, in-house python
scripts can be used to look for conservative/non-
conservative nsSNPs across classes of amino acids and
change of nsSNP to cysteine and vice versa. Evolutionary
conservation of nsSNPs across multiple species including
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FIGURE 4 | A schematic overview of the work flow to analyze nsSNPs.
Macaca mulatta, Pan troglodytes, Mus musculus, Rattus
norvigicus, Bos taurus, Canis lupus familiaris (dog),
Equus caballus (horse), Gallus gallus (chicken) and
Danio rerio can be studied. Local alignment can be
generated encompassing variant using European Molecular
Biology Open Software Suite (EMBOSS) and conservation
of variant could be checked using in-house Python
scripts.
Further, available tools for the prediction of biological
effect of nsSNPs such as polymorphism phenotyping-2
(PolyPhen -2) [PMID: 20354512] considers sequence and
structural feature of proteins; Sorting Intolerant From
Tolerant [SIFT; PMID: 12824425] is based on evolutionary
conservation of protein sequences; SNPs3D [PMID:
16551372] is based on protein sequence conservation,
protein structure and stability; PMUT [PMID: 15879453]
scans mutational hot spots in three-dimensional structure of
proteins and TopoSNP [PMID: 14681472] uses geometric
location of nsSNPs in three- dimensional structure
of protein, can be used. Variant amino acid residue
can be searched via Online Mendelian Inheritance in
Man (OMIM) database in order to infer nsSNPs to be
damaging.
Novel changes can be evaluated for their potential effect
on the protein structure and function using bioinformatics
tools. Together these approaches provide a useful tool which
can be very useful in describing the AMD spectrum among
Indians.
CONCLUSION
AMD is a genetically heterogeneous disease which could
be equally influenced with environmental factors. Most of
population/epidemiological studies in AMD are confined
up to the genetic analysis of various genes and their
association with pathology progression. Here, we tried
to describe the integrative approach in AMD genetics
by combining demographic and genetic data, and thus
ultimately can propose statistical model for the same for
better management of disease prognosis and diagnostic
field. Bio-informatics approach could also assist the nature
of SNP variant by analysing the impact of SNP changes
in the structural and functional aspect of the particular
protein.
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